A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity

NCT07160400 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Part A: Healthy Part B: Overweight or Obesity

Interventions

DRUG: Placebo
DRUG: IBI3032 tablets

Sponsor

Innovent Biologics Technology Limited (Shanghai R&D Center)